Gardasil 9 Vaccine
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Gardasil 9 Vaccine is a 9-valent human papillomavirus (HPV) vaccine. Its labelling describes it as being given to help protect against several HPV strains, including those associated with cervical, vaginal, vulvar and anal cancers and genital warts, and it is described for people of any gender aged 9 to 45 years. It is described as stimulating the immune system to respond to HPV, which is described as lowering the chance of developing HPV-related disease.
Product Information
The following description reflects information associated with the 9-valent human papillomavirus (HPV) vaccine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the prevention of HPV-associated cancers, including cervical, vaginal, vulvar and anal cancers
- Described for the prevention of genital warts (skin bumps on or around the genital or anal area) caused by HPV
- Described for people of any gender aged 9 to 45 years; described as giving better protection when the full series is completed
Described How It Works
Its labelling describes the vaccine as helping the immune system produce antibodies that can stop the human papillomavirus from infecting body cells. It does not contain live virus capable of causing HPV disease.
Described Dosage & Administration
- Administered only by a doctor or nurse as an intramuscular injection, usually in the upper arm or thigh — not self-administered
- Given as a series of doses over several months, on the schedule set by the healthcare provider
- The full series should be completed as prescribed to maximise protection against HPV
Described Side Effects
Commonly described side effects include:
- Injection-site reactions (pain, swelling, redness)
- Headache
- Dizziness
- Nausea
- Tiredness and fever
These are described as usually mild and temporary. A doctor should be consulted if they persist, and any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- Medical history and a list of current medicines should be shared with the doctor before administration
- Any previous allergic reaction to a vaccine or vaccine component should be disclosed before administration
- It is described as not a replacement for cervical screening; scheduled screening appointments should still be attended
- Pregnancy or breastfeeding should be discussed with the doctor before the vaccine is given
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it is a 9-valent HPV vaccine given to help prevent HPV-associated cancers (cervical, vaginal, vulvar and anal) and genital warts, for people of any gender aged 9 to 45 years. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as given by a doctor or nurse as an intramuscular injection in the upper arm or thigh, as a series of doses over several months. The full series should be completed as prescribed.
No. Its labelling describes the vaccine as not a replacement for cervical screening — scheduled screening appointments should still be attended.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.